Comparisons of BCR::ABL1IS ≤1% and MMR among patients with CP-CML without the T315I mutation with baseline BCR::ABL1IS >10% are presented in Supplementary Table S2. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.